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Crohn’s disease (CD) is an inflammatory bowel disease characterized by an
exaggerated immune response to commensal microbiota in the intestines of
patients. Metagenomic studies have identified specific bacterial species and
strains with increased prevalence in CD patients, amongst which is the adherent-
invasive Escherichia coli (AIEC) strain LF82. AIEC strains express long polar
fimbriae (LPF), which are known to target Peyer’s patches in a mouse CD
model. Here, the recombinant production of a soluble, self-complemented
construct of the LpfD protein of E. coli LF82 is reported and it is demonstrated
that it forms the adhesive tip subunit of LPF. The LpfD crystal reveals an
N-terminal adhesin domain and a C-terminal pilin domain that connects the
adhesin to the minor pilus subunit LpfE. Surface topology and sequence
conservation in the adhesin domain hint at a putative receptor-binding pocket as
found in the Klebsiella pneumoniae MrkD and E. coli F17-G (GafD) adhesins.
Immunohistostaining of murine intestinal tissue sections revealed that LpfD
specifically binds to the intestinal mucosa and submucosa. LpfD binding was
found to be resistant to treatment with O- or N-glycosidases, but was lost in
collagenase-treated tissue sections, indicating the possible involvement of an
intestinal matrix-associated protein as the LpfD receptor. LpfD strongly
adhered to isolated fibronectin in an in vitro assay, and showed lower levels of
binding to collagen V and laminin and no binding to collagens I, III and IV.
1. Introduction
Crohn’s disease (CD) is an inflammatory disease of the
gastrointestinal tract, the pathogenesis of which is a complex
interplay of genetic susceptibility and an excessive immune
response to enteric bacteria, leading to tissue injury (Binder &
Orholm, 1996; Shanahan, 2002). In healthy individuals, the
intestinal mucosa and its immune system act as a sensor of the
microenvironment and are in a state of constant, controlled
low-grade inflammation (Fiocchi, 2005). However, genetically
predisposed individuals can exhibit an altered regulation of
the mucosal immune response, leading to uncontrolled
inflammation as a reaction to otherwise harmless, commensal
microorganisms (Macpherson et al., 1996; Cario & Podolsky,
2000; Eckburg & Relman, 2007). In recent years, increased
attention has been paid to the role of dysbiosis in the intestinal
microbiota and the possible involvement of specific,
presumptively infectious, components in initiating and/or
exacerbating inflammatory bowel diseases such as CD
(Manichanh et al., 2006; Sartor, 2010; Willing et al., 2010).
ISSN 1399-0047
# 2015 International Union of Crystallography
Although the aetiology of intestinal dysbiosis is as yet
unclear, a series of gut metagenome studies have consistently
pointed to decreased microbial diversity in patients with CD,
often with a concomitant increase in Enterobacteriaceae,
including Escherichia coli and Ruminococcus gnavus (Mani-
chanh et al., 2006; Frank et al., 2007). Darfeuille-Michaud and
coworkers previously observed an abnormal increase in E. coli
associated with resected ileal CD lesions (Darfeuille-Michaud
et al., 1998). The strains isolated from such CD lesions were
originally believed to lack the typical virulence factors known
from E. coli pathovars that cause acute enteric disease [e.g.
enterotoxigenic E. coli (ETEC), enteroinvasive E. coli
(EIEC), enteropathogenic E. coli (EPEC), enterohaemor-
rhagic E. coli (EHEC), diffuse adherent E. coli (DAEC) or
enteroaggregative E. coli (EAEC)], but in most cases
demonstrated in vitro mannose-resistant (i.e. independent of
type 1 pili) adherence to intestinal epithelial cells. In addition,
such strains invade and replicate within intestinal epithelial
cells and macrophages (Boudeau et al., 1999). Genome
analysis of LF82, a reference CD-associated isolate, showed
that this adherent-invasive E. coli (AIEC) most closely
resembles group B2 extraintestinal pathogenic E. coli
(ExPEC) such as the avian and uropathogenic strains
APEC01 and UTI89 (Miquel et al., 2009). The enrichment of
AIEC in CD patients has been suggested to be associated, at
least in part, with abnormal overexpression of CEACAM6
(carcinoembryonic antigen-related cell adhesion molecule 6)
as a result of bowel inflammation, which then acts as a
mannosylated receptor for type 1 pili (Barnich et al., 2007).
More recently, long polar fimbriae (LPF) have been shown to
be responsible for mannose-insensitive adherence of AIEC to
murine Peyer’s patches (PP; Chassaing et al., 2011). LPF-
dependent adherence to M cells on the surface of human and
murine PP leads to efficient invasion and translocation of
AIEC across the epithelial barrier (Chassaing et al., 2011).
The name long polar fimbriae was coined following the
detection by electron microscopy of long (2–10 mm) filaments
at one or both poles of nonfimbriated E. coli (fim mutant)
transformed with a cosmid carrying the lpf operon from
S. enterica serovar Typhimurium (Ba¨umler & Heffron, 1995).
The typical lpf gene cluster consists of five genes, which based
on homology to other fimbrial operons can be annotated as a
periplasmic chaperone (LpfB) and an outer membrane usher
(LpfC) that together make up the pilus-assembly machinery,
as well as the predicted fimbrial subunits LpfA, LpfD and
LpfE (Ba¨umler & Heffron, 1995). The term ‘long polar
fimbriae’ is used generically, as the LPF in different species or
pathotypes exhibit somewhat different properties and show at
least two paralogous lineages (Fig. 1). The lpf operon in
Salmonella is involved in adhesion to the murine intestinal
tract, more specifically to the PP. Lpf-mutant Salmonella
exhibits an increased LD50 in mice, as well as a delayed action
(Ba¨umler et al., 1996). Two lpf-like operons were subsequently
also identified in enterohaemorrhagic E. coli (EHEC) and
AIEC (Torres et al., 2002; Fig. 1).
EHEC strain O157:H7 contains
two non-identical operons, lpf1
and lpf2, with the former being
the closer homologue to the LPF
found in S. enterica serovar
Typhimurium (Fig. 1). The lpf1
operon contains lpfABCC0DE
and is located on O-island 141,
between yhjX and yhjW (of the
E. coli K12 chromosome; Torres
et al., 2002). The lpf2 operon in
EHEC is located on O-island 154
of the O157:H7 chromosome, in
the same locus as the lpf operon
of E. coli O113:H21, and contains
the genes lpfABCDD0 (Torres et
al., 2004). Both gene clusters have
been shown to influence the
intestinal colonization and
persistence of EHEC strain
O157:H7 (Jordan et al., 2004;
Torres et al., 2007). EHEC
O157:H7 adheres to PP follicle-
associated epithelium of in vitro-
cultured human intestines and
causes localized attaching/effa-
cing (A/E) lesions. In the case of
lpf1 or lpf2 single mutants, as well
as the lpf1/lpf2 double-knockout
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Figure 1
Schematic representations of the lpf and fim operons in S. enterica Typhimurium and E. coli, with colour
fillings according to (predicted) homology and numerical values representing the percentage of amino-acid
sequence identity and similarity to the corresponding protein in E. coli LF82.
mutant, the bacteria still caused A/E lesions, but lost tropism
to the follicle-associated epithelium (Fitzhenry et al., 2006).
LPF in EHEC have also been reported to play a role in the
inflammatory response of infected cells by upregulating the
induction of pro-inflammatory cytokines (Farfan et al., 2013).
However, the exact role as well as the receptor-binding profile
of either lpf operon in E. coli O157:H7 remains unclear. On
top of the split into lpf1 and lpf2 paralogues, analysis of lpfA1
sequences (major fimbrial subunit) has shown a phylogenetic
subgrouping of five lpfA1 variants which correlated with the
intimin types expressed by the various pathogenic E. coli
strains (Torres et al., 2009). AIEC possesses Lpf variant 1–2,
with the closest similarity to EHEC O111:H8, and is distinct
from EHEC O157:H7 (Lpf1–3) and EPEC O127:H6 (Lpf1–1)
(Torres et al., 2009). The functional significance of the Lpf1
subgrouping is as yet unclear.
To obtain a better understanding of the molecular action of
LPF-mediated adherence to enteric epithelial cells, we hypo-
thesized that LpfD is the LPF adhesin, and produced a soluble,
self-complemented construct, determined its three-
dimensional structure and analysed its adhesive properties.
We report the X-ray structure of LfpD from AIEC strain LF82
fused to the N-terminal extension peptide of the LpfE subunit
and, using immunohistostaining of murine ileal tissue sections
and in vitro binding studies, we demonstrate that LpfD
encompasses the LPF adhesin and specifically binds to a
matrix component in the enteric epithelium.
2. Materials and methods
2.1. Cloning, expression and purification
The LpfD coding sequence was PCR-amplified from E. coli
LF82 (NCBI RefSeq YP_002558392.1), with an addition
through primer extension at the 30 end of a sequence encoding
a ten-glycine linker as well as the 20 N-terminal residues of the
LpfE minor subunit (ATTDLGAKGTLKFSLKISQG) or the
17 N-terminal residues of LpfA (ADAGDGSVKFTGEIV-
DA), followed by a 6His tag, and cloned in the pDEST14
plasmid for periplasmic expression using the Gateway tech-
nique (Invitrogen). The resulting plasmids (pJI1 and pJI2,
respectively) were transformed into E. coli C43(DE3) cells,
which were grown in 12 l LB broth supplemented with
100 mg ml1 ampicillin under constant aeration at 37C.
Expression was induced by the addition of a 0.5 mM final
concentration of isopropyl -d-1-thiogalactopyranoside
(IPTG) when the cells reached an OD of 0.7 and was allowed
to continue for 18 h at 28C. The cells were harvested by
centrifugation at 4000g for 15 min and were resuspended in
3 ml sucrose buffer per gram of wet cells (20% sucrose, 20 mM
Tris pH 8.5, 5 mM EDTA, 0.1 mg ml1 lysozyme) and stirred
for 20 min at 4C. Centrifugation at 13 000g for 45 min yielded
the periplasmic extract, which was dialysed overnight against
dialysis buffer (20 mM Tris pH 8.5, 150 mM NaCl) at 4C.
20 mM imidazole and 10 mM MgCl2 (to chelate the EDTA)
were added to the periplasmic extract before ultra-
centrifugation (Beckman Coulter Optima L-90K, 45 Ti rotor,
30 000 rev min1, 30 min, 4C) to remove the insoluble parti-
cles prior to chromatography.
LpfD fused to the first 20 residues of LpfE (LpfDENte) was
purified by Ni-affinity chromatography followed by hydro-
phobic interaction chromatography: the cleared periplasmic
extract was loaded onto a 5 ml HisTrap FF column (GE)
equilibrated in buffer A (20 mM Tris pH 8.5, 150 mM NaCl,
20 mM imidazole), after which the column was washed with
buffer A. The recombinant protein was eluted with a gradient
to elution buffer (20 mM Tris pH 8.5, 150 mM NaCl, 500 mM
imidazole) and the fractions containing the protein of interest
were pooled and supplemented with 1.5 M ammonium sulfate.
After filtration through a 0.45 mm pore-size filter, the sample
was loaded onto a 1 ml Phenyl FF low-sub (GE) column
equilibrated in buffer C (20 mM Tris pH 8.5, 1.5 M ammonium
sulfate). Elution was with 20 mM Tris pH 8.5 buffer using a
gradient over 30 column volumes. The protein was concen-
trated to 3.6 mg ml1 using a 10K MWCO Amicon concen-
trator.
2.2. Crystallization and data collection
The concentrated protein was screened against sparse-
matrix crystallization screens using the sitting-drop vapour-
diffusion method in 96-well MRC plates (Molecular Dimen-
sions) incubated at 20 containing 70 ml well solution and
drops consisting of 0.4 ml protein solution and 0.2 ml well
solution. 29 hits were observed using JBScreen PACT++ (Jena
Bioscience) and were optimized by modifying the precipitant
concentration and using 48-well pre-greased hanging-drop
plates with crystallization drops consisting of 2.0 ml protein
solution and 1.0 ml well solution. Crystals obtained in the
condition 0.1 M Tris pH 8.0, 0.18 M sodium citrate, 20% PEG
3350 were used to solve the structure of LpfDENte.
Native crystals were mounted on a cryoloop and passed
through a Paratone layer for cryoprotection before flash-
cooling.
Experimental phases were obtained through the iodination
of Tyr. Since iodination of proteins is a well known labelling
technique and iodination of tyrosines has already been
achieved after crystal formation and successfully used for
phasing (Ghosh et al., 1999), a slightly modified protocol, using
only iodine and no iodide, was attempted and was found to be
successful. A tiny chunk of I2 was fixed with silicone grease
onto the side of the well (hanging drop) containing the
selected crystal and allowed to sublime and diffuse overnight
in the closed well. Following overnight incubation the crystal
was mounted on a cryoloop, soaked in well solution supple-
mented with 15% glycerol for cryoprotection and flash-cooled
in liquid N2.
X-ray diffraction data were collected on the PROXIMA 1
beamline at SOLEIL, Saint-Aubin, France tuned to 6.8 keV
and equipped with a Pilatus 6M detector.
One data set was collected from an LpfDENte–I2 crystal
using an inverse-beam protocol and indexed and scaled using
XDS and XSCALE (Kabsch, 2010). The space group was
determined to be C2221, and SHELXC and SHELXD were
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used to locate anomalous scattering sites (Sheldrick, 2008).
The AutoSol and AutoBuild workflows from PHENIX
(Adams et al., 2010) were run successively, followed by manual
rebuilding and maximum-likelihood refinement using Coot
and REFMAC, respectively (Emsley et al., 2010; Murshudov et
al., 2011).
Two data sets were also collected from the LpfDENte native
crystal at 12.65 keV and were processed and scaled as
described above. The model obtained from the LpfDENte–I2
data sets was further refined using the native data, ultimately
resulting in a model with 1.8 A˚ resolution and an Rwork and
Rfree of 0.17 and 0.19, respectively, which was deposited in the
PDB with accession code 5afo.
2.3. Fluorescence microscopy
Purified LpfDENte in 20 mM HEPES pH 7.5, 150 mM NaCl,
5% glycerol was fluorescently labelled with DyLight 650
amine-reactive dye (Thermo Scientific). Unbound dye was
removed by three successive dialyses against 20 mM HEPES
pH 7.5, 150 mM NaCl, and a sample of the last dialysis buffer
after equilibration was used as the blank in the microscopy
experiments.
The protocol used for the in situ binding assay is based on
that of Johansson & Hansson (2012). C57BL/6WT mice were
sacrificed according to Belgian regulations and the bladder
and small intestine were dissected and fixed with methanol-
Carnoy mixture for a minimum of 3 h at room temperature.
The fixed tissues were embedded in paraffin and 4 mm thin
sections were made and put on glass slides. Prior to labelling,
deparaffinization and rehydration of the sections was
performed by incubation of the slides for 2  3 min in xylene,
2-propanol, 100% ethanol and 70% ethanol, respectively,
followed by rinsing in tap water and PBS. Some of the slides
were pre-treated overnight at 37C under shaking conditions
with either O-glycosidase (NEB Enzyme; 40 000 units in 5 ml
50 mM sodium phosphate buffer pH 7.5), PNGase (NEB
Enzyme; 5 U in 5 ml 250 mM sodium phosphate buffer pH 7)
or 250 ml collagenase mix in 5 ml PBS (10 U ml1 collagenase
type I, 400 U ml1 collagenase type IV, 30 U ml1 DNase I).
The PNGase and O-glycosidase activity was assessed by the
observation of markedly reduced binding of FimH and peanut
lectin, respectively. After several washes with PBS, the slides
were incubated in blocking buffer (PBS + 5% FCS) at room
temperature for 30 min before counter-staining with Hoechst
stain (1:1000 in PBS) for 10 min at room temperature. After
three washes with PBS, the sections were incubated with anti-
Muc2 mucin primary antibody [1:200; mucin 2 (H-300) rabbit
polyclonal IgG, Santa Cruz Biotechnology] for 2 h. After three
washes with PBS, the slides were incubated with goat anti-
rabbit DyLight 488 secondary antibody (1:1000 dilution) in
blocking buffer for 1 h at room temperature. Incubation with
10 mg of the labelled LpfDENte in blocking buffer alone, in
blocking buffer with mouse naive serum or in blocking buffer
with mouse serum raised against LpfDENte took place at 4
C
overnight. Slides were finally washed with PBS five times
before mounting with fluorescence mounting medium
(n-propyl gallate in glycerol) and were observed with a Leica
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Figure 2
Fluorescence microscopy experiments on murine small intestine (a, b, c, d, g, h) and bladder (e, f ) sections. Sections were incubated with (a, e) the last
dialysis buffer after DyLight 650 labelling as a blank, (b, f, g, h) DyLight 650-labelled LpfDENte, (c) DyLight 650-labelled LpfDENte with murine naive
serum and (d) DyLight 650-labelled LpfDENte with mouse polyclonal anti-LpfD serum. Slides (g) and (h) were pre-treated prior to incubation with
LpfDENte with (g) O-glycosidase or (h) PNGase. Blue is Hoechst stain of DNA, green is Muc2 antibody and red is LpfDENte labelled with DyLight 650.
confocal microscope (Leica Microsystems LAS-AF-TCS SP5)
with a 20  125 objective. All of the pictures were taken using
the same microscope settings and the Fiji software was used to
process the data. The selected images are representative of
multiple experiments on nonconsecutive tissue sections.
Where nonconsecutive intestinal regions are shown in
different panels of Fig. 2, these were individually compared
with positive and negative controls (i.e. + or  LpfDENte) on
near sections (not shown) to minimize nonspecific staining
differences.
2.4. ELISA assay
LpfD binding to ECM proteins was evaluated as described
previously (Farfan et al., 2011). Briefly, 96-well microtitre
plates (Nunc) were coated with a solution of 10 mg ml1
collagen type I (collagen from rat tail, Bornstein and Traub
type I; Sigma), collagen type III (collagen from human
placenta, Bornstein and Traub type III; Sigma), collagen type
IV (collagen from human placenta, Bornstein and Traub type
IV; Sigma), collagen type V (collagen from human placenta,
Bornstein and Traub type V; Sigma), laminin (from human
placenta; Biopur) and fibronectin (from human plasma;
Sigma) per well overnight at 4C. Unbound protein was
removed and blocked with 1% bovine serum albumin (BSA;
Sigma) for 2 h at 37C. LpfDENte at 10 mg ml
1 was added to
the ECM protein-coated wells and incubated for 90 min at
room temperature. As negative and positive controls, wells
were coated with PBS or LpfDENte (10 mg ml
1), respectively.
After three washes with PBS and Tween, wells were incubated
with the primary antibody, a 1:500 dilution of anti-His mAB
(Serotec). Wells were subsequently washed (three times) and
bound antibodies were detected by incubation with a goat
anti-mouse IgG alkaline phosphatase-conjugated secondary
antibody (1:500 dilution; Sigma–Aldrich). Binding was
revealed with p-dinitrophenylphosphatase (p-DNPP; Sigma)
as a substrate. Absorbance values were measured at 405 nm
after 15 and 60 min. The values after 60 min are plotted in
Fig. 7(b).
2.5. Bioinformatics tools
To map the conservation of residues onto the LpfD struc-
ture, 205 E. coli LpfD protein sequences were obtained from
the PiliomeDB database (http://www.piliomedb.org). By
filtering out truncates and selecting only one representative
for each group of identical sequences, 13 sequences remained
(E. coli strains/GenBank accession Nos. O55:H7/AEZ42654.1,
KO11FL/AFH15989.1, O157:H7/AAG58691.1, 55989/
CAV00473.1, IAI1/CAR00505.1, O127:H6/CAS11343.1,
O103:H2/BAI33386.1, O111:H-/BAI38125.1, O55:H7/
ADD58754.1, O26:H11/BAI28212.1, O83:H1/ADR28936.1,
W/ADT77155.1 and LF82/CAP78003.1)
A multiple alignment of these sequences was used to
compute residue frequencies for each column, which were
then mapped onto the LpfD surface-filling model using a
custom Python script developed in-house. Multiple sequence
alignments were performed with MUSCLE (Edgar, 2004) and
visually represented with WebLogo (Crooks et al., 2004), and
structural alignments were performed with the DALI server
(Holm & Rosenstro¨m, 2010). Identity and similarity values
were calculated by EMBOSS Needle (McWilliam et al., 2013),
interface buried surface area was calculated with PDBePISA
(http://www.ebi.ac.uk/pdbe/prot_int/pistart.html; Krissinel &
Henrick, 2007) and secondary-structure prediction was
performed with PSIPRED (Buchan et al., 2013). Figures were
prepared with MacPyMOL (PyMOL v.1.3; Schro¨dinger).
3. Results and discussion
3.1. LpfD is responsible for the adhesion of LPF
The adhesive properties of chaperone–usher pili are either
found integrated into polymerizing single-domain subunits
that are distributed throughout the length of the fibre (single-
domain adhesins or SDAs) or as two-domain adhesins (TDA)
found as a single copy located at the distal tip of the pilus (De
Greve et al., 2007). Based on secondary-structure predictions,
its localization in the LPF gene cluster (Fig. 1) and its
homology to FimH [LpfD from E. coli LF82 (NCBI RefSeq
YP_002558392.1) and FimH from S. enterica Typhimurium
share 27 and 42% sequence identity and sequence similarity,
respectively], we hypothesized that mature LpfD would be a
putative TDA. In known TDAs, the adhesive properties are
located in an N-terminal -sandwich domain, whilst the
C-terminal domain forms an incomplete Ig domain that
connects the subunit to the pilus through a noncovalent donor-
strand complementation reaction with an N-terminal exten-
sion (Nte) of the next subunit in the row (Choudhury et al.,
1999). As such, isolation of a stable TDA can only be
performed (i) as a binary complex with its chaperone
(Choudhury et al., 1999), (ii) as a fragment corresponding to
the N-terminal adhesin domain only (Dodson et al., 2001) or
(iii) in a donor-strand exchanged (DSE) complex with its
cognate N-terminal extension peptide, either noncovalently or
as a self-complemented construct in which a complementing
Nte is fused to the C-terminus of the adhesin (Barnhart et al.,
2000; Sauer et al., 2002). For LPF, attempts to produce a stable
complex of LpfD and the LpfB chaperone were unsuccessful.
Similarly, the expression of constructs corresponding to the
predicted N-terminal domain did not result in a stably folded
protein. Therefore, we followed a route to generate Nte-
complemented LfpD. As it is presently unknown whether
LpfD is attached to the LpfE or LpfA subunits inside LPF,
we made self-complemented constructs by fusing the protein
to either the first 20 residues of LpfE (hereafter referred to as
LpfDENte) or the first 17 residues of LpfA (hereafter referred
to LpfDANte), in both cases preceded by a ten-glycine linker to
allow the Nte to attain its binding conformation and followed
by a 6His tag for metal-ion affinity purification. Although
LpfDANte was found to be expressed in the periplasm
(Supplementary Fig. S1), it did not represent a stable protein
that was amenable to purification. By comparison, LpfDENte
formed a stable, soluble fusion product that could be purified
from the periplasm in high yields. Together, these data
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suggested that the LpfE Nte forms the natural complementing
strand of LpfD.
To determine whether LpfD represents the LPF adhesin
and has glycan-binding properties, as observed for most other
fimbrial tip adhesins, the purified LpfDENte was sent to the
Consortium for Functional Glycomics (CFG). The recombi-
nant protein was subjected to a protein–glycan interaction test
by exposure to version 5.1 of the glycan array, which consists
of 610 immobilized glycans in six replicates. This failed to show
statistically significant binding to any of the glycans present
in the CFG 5.1 array (the data are publicly available at http://
www.functionalglycomics.org, accession code cbp_2960). We
next examined whether the LpfD subunit indeed confers the
adhesive properties of LPF. Therefore, purified LpfDENte was
fluorescently labelled with DyLight 650 and the binding of the
protein to mouse intestinal tissue sections was monitored by
fluorescence microscopy (Fig. 2). The purified, DyLight 650-
labelled LpfDENte was found to abundantly bind the intestinal
epithelium and PP of mouse small intestine tissue sections
(Figs. 2a and 2b). A co-incubation with mouse polyclonal anti-
LpfD serum, but not naive mouse serum, abolished LpfDENte
binding to the ileal tissue section (Figs. 2c and 2d). To assess
whether LpfDENte binding was specific to intestinal tissue,
murine bladder epithelium sections were incubated with
DyLight 650-labelled LpfDENte but failed to show binding of
the protein (Figs. 2e and 2f). Previously reported binding
studies obtained with whole E. coli LF82 expressing LPF
showed that bacterial binding to mouse ileal loops or isolated
human PPs was localized to the PP-associated M cells only
(Chassaing et al., 2011). By comparison, using the purified
LpfDENte protein, we find a broader binding profile that, in
addition to the M-cell binding in the PP, includes goblet and
columnar epithelium cells in the intestinal epithelium (Figs. 2b
and 2c). Co-staining with a Muc2 antibody shows that the
LpfDENte binding is cell-associated and is absent in the luminal
mucin secretions. We propose that this apparent discrepancy
in LPF binding tropism stems from the inability of the whole
bacteria to penetrate the overlaying mucus layer in the context
of an intact mucosa. Our results suggest the LpfD receptor is
present throughout the ileal epithelium, but becomes acces-
sible to bacteria only in places with reduced mucus shielding,
as is the case at the PP.
Most fimbrial adhesins bind to specific glycoreceptors
presented in the form of glycoproteins, glycolipids or matrix
glycans (De Greve et al., 2007). To evaluate whether the
negative glycan-array analysis of LpfDENte could stem from
the absence of the natural LpfD glycan receptor in the version
5.1 array, we subjected mouse ileal tissue sections to
O-glycosidase or PNGase treatment to remove O- or N-linked
glycans, respectively, prior to incubation with LpfDENte.
Neither treatment abolished LpfDENte binding (Figs. 2g and
2h), although PNGase-treated ileal sections seemed to show a
reduced binding in the underlying PP but not at the intestinal
epithelium.
3.2. Structural analysis of LpfD
To obtain structural insight into the adhesive properties of
LpfD, purified LpfDENte protein (Fig. 3a) was concentrated to
3.6 mg ml1 and subjected to crystallization and structure
determination through X-ray crystallography. The polyhedral
crystals (Fig. 3b) obtained in the crystallization condition
0.1 M Tris pH 8.0, 0.18 M sodium citrate, 20% PEG 3350
diffracted to 2.2 A˚ resolution and were experimentally phased
using a single anomalous dispersion (SAD) experiment on a
tyrosine-iodinated crystal. The structure was built and further
refined to 1.8 A˚ resolution using data collected from a native
crystal, resulting in a final model with an Rwork and Rfree of 0.17
and 0.19, respectively (Figs. 3c and 3d, Table 1), a MolProbity
score of 2.00 and with 98.4% of the residues lying in the most
favoured regions of the Ramachandran plot.
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Figure 3
(a) SDS–PAGE showing the purity of the crystallized recombinant
LpfDENte obtained after nickel-affinity chromatography followed by
hydrophobic interaction chromatography. (b) A hanging-drop vapour-
diffusion crystallization experiment with condition 0.1 M Tris pH 8.0,
0.18 M sodium citrate, 20% PEG 3350 containing crystals of LpfDENte.
(c, d) Detail of the refined structure model (residues 90–95) overlaid with
(c) the density-modified experimental electron-density map contoured at
1.5 (grey) and the anomalous density (blue) contoured at 3.0 or (d) the
refined 2Fo  Fc electron-density map contoured at 1.5.
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The structure of LpfD comprises two independent domains,
similar to the architecture observed for fimbrial tip adhesins
such as FimH (Choudhury et al., 1999). Both the N-terminal
adhesin and the C-terminal pilin domain of LpfD show a
-sandwich pattern connected by a short linker (residues 180–
183 of the mature protein; Figs. 4b and 4d). The pilin domain
has an incomplete Ig-like fold, lacking the last -strand, which
is complemented by 17 of the 20 added residues corresponding
to the first -strand of LpfE (Figs. 4b and 4c, green and
magenta). Residue Ile17 of the N-terminal extension has its
side chain pointing towards the hydrophobic core of the pilin
domain of LpfD, thereby filling the cavity known as the P5
pocket, in an analogy to the numbering convention used for
the Pap system (Sauer et al., 2002) and other chaperone–usher
systems undergoing DSE. Residues Leu15, Phe13 and Leu11
fill the P4, P3 and P2 pockets, respectively, stabilizing the pilin
domain through hydrophobic interactions. This pattern is
somewhat different from that observed in subunits of the Pap
and Fim systems, in which the P4 forms a shallow pocket that
accepts a Gly residue in the N-terminal extension (Sauer et al.,
2002; Puorger et al., 2008) and is more reminiscent of the pilin–
Nte interactions observed in the Yersinia pestis Caf and
S. enterica Saf pilus systems (Zavialov et al., 2003; Remaut et
al., 2006). Similar to the latter, LpfE reveals an extended Nte
that inserts a bulky residue, Leu5, into a hydrophobic pocket
outside the Nte acceptor groove, referred to as the P* pocket
in the case of the Saf system (Remaut et al., 2006). As
expected, no electron density was observed for the ten-glycine
linker used to covalently link the C-terminus of LpfD to the
first N-terminal residue of the Nte of LpfE in LpfDENte. The
binding interactions of the LpfE Nte in the LpfD acceptor
groove provide another pointer to the subunit order found in
the LPF. Alignment of the LpfA and LpfE N-terminal
sequences (Fig. 4a) shows that the former would form a
suboptimal donor strand for interaction with the LpfD
acceptor groove, as amino-acid substitutions at the P4
(Leu!Gly), P2 (Leu!Val) and P* (Leu!Asp) positions
Figure 4
(a) Alignment of the N-terminal extensions of LpfE and LpfA. The P2, P3, P4 and P5 residues are indicated in magenta and the P* residue in orange. (b)
Cartoon model of the structure of LpfD; the adhesin domain is shown in dark blue and the pilin domain is in red, with the complementing first -strand of
LpfE in green and magenta (P5–P2 residues). (c) Hydrophobic interactions between the N-terminal extension of LpfE and the core of the pilin domain
of LpfD. Residues filling the P2–P5 pockets are shown in magenta and Leu5 filling the P* pocket is shown in cyan. (d) Topology diagrams of the adhesin
domain (top) and the pilin domain (bottom) of LpfD. The complementing N-terminal extension of LpfE is shown in green.
would result in a destabilizing loss of hydrophobic contacts in
the DSE interaction. Indeed, when complemented with the
LpfA Nte, LpfD did not form a stable soluble fusion protein
(see above). Together, these results suggest an LPF archi-
tecture in which LpfD forms the capping tip adhesin that is
connected to the pilus rod via the LpfE subunit.
To date, experimental structures of six fimbrial TDAs are
available, F17-G (GafD; PDB entry 1o9w; Buts et al., 2003),
FimH (PDB entry 3jwn; Le Trong et al., 2010), PapG (PDB
entry 1j8s; Dodson et al., 2001), FedF (PDB entry 4b4p;
Moonens et al., 2012), MrkD (PDB entry 3u4k; Reˆgo et al.,
2012) and CfaE (PDB entry 3vac; Liu et al., 2013), of which
just two comprise the full-length protein including the pilin
domain (Le Trong et al., 2010; Liu et al., 2013). In different tip
adhesins, the interdomain region forming the contact between
the lectin and pilin domains of the adhesin has been found to
play an important role in conformation and ligand-binding
affinity (Thomas et al., 2002; Yakovenko et al., 2008; Liu et al.,
2013; Stahlhut et al., 2013). The interaction mode and role of
the interdomain region has been characterized structurally for
the E. coli adhesins FimH and CfaE (Le Trong et al., 2010; Liu
et al., 2013). The FimH lectin domain contacts the pilin domain
through two loops situated at the base of the lectin domain.
Although 35 A˚ away from the mannose-binding pocket, the
absence of the pilin domain or disruption of the interdomain
contact by the application of mechanical force causes the
lectin domain to adopt an elongated higher-affinity confor-
mation (Le Trong et al., 2010). This elongated conformation is
propagated throughout the lectin domain via the distortion of
a -sheet, ultimately influencing the loops of the binding
pocket and resulting in the shear-enhanced binding properties
of the adhesin (Le Trong et al., 2010). The interdomain
interface of CfaE also appears to play a role in ligand-binding
affinity, as was shown by introducing bulkiness in this inter-
domain plane (Liu et al., 2013). In LpfD, the interdomain
region corresponds to a 383 A˚2 solvent-buried surface area
(Krissinel & Henrick, 2007) encompassing residues 24–32,
139–143 and 179 in the lectin domain, residues 184, 227–230
and 288–290 in the pilin domain and residues 180–183 of the
linker. The LpfD interdomain region shows a high degree of
sequence conservation compared with that observed in the
lectin domain (Fig. 5). This includes contacts by residue Val142
(conservatively mutated to Ile142 in 20% of LpfD poly-
morphs) and a defined hydrophobic pocket on the nearby
surface of the pilin domain. Whether LpfD shows a shear-
enhanced binding profile is presently unknown; sequence
conservation in the interdomain contact zone argues at least
for a role in maintaining a rather fixed angle between both
domains in the absence of a pulling force (Fig. 5).
3.3. In search of the receptor and binding site of LpfD
In the absence of an experimentally identified LpfD
receptor, we sought structure-guided clues pointing to the
LpfD receptor-binding site and candidate receptors by
comparison with fimbrial adhesins of known structure. When
looking at sequence conservation of
surface-exposed residues in the LpfD
adhesin (Fig. 6a), a striking difference is
seen between the N- and C-terminal
domains. Whilst the pilin domain exhi-
bits a high degree of sequence conser-
vation, the putative adhesin domain
reveals a high degree of sequence
variation for the most part of its surface.
We postulate that this increased
sequence divergence is indicative of a
selective pressure to escape neutralizing
immune responses directed to the
receptor-binding domain. Contrary to
the residues in the immediate receptor-
binding site, which are expected to be
under a strong negative selection to
maintain epitope recognition, residues
surrounding the binding site can be
expected to undergo episodic sweeps of
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Figure 5
Close-up view of the interaction between the adhesin and pilin domains of LpfD. The pilin domain
is shown as a surface-filling model and the adhesin domain as a cartoon model, with the residues
corresponding to the ‘swing’ loop shown as stick models. Residues are coloured blue/white/yellow
according to sequence conservation, with blue and yellow the highest and the lowest level of
conservation, respectively. The N-terminal extension of LpfE is shown in green.
Table 1
Data-collection and refinement statistics.
Beamline PROXIMA 1
Wavelength (A˚) 0.98011
Space group C2221
Unit-cell parameters (A˚) a = 49.01, b = 372.13, c = 99.03
Molecules per asymmetric unit 2
Resolution range (A˚) 48.59–1.82 (1.883–1.818)
Unique reflections 82152 (8034)
Completeness (%) 99.88 (98.86)
Multiplicity 11.6
Rmeas (%) 6.7 (83.3)
Mean I/(I) 24.04 (3.26)
Wilson B factor (A˚2) 23.15
Rwork/Rfree 0.172/0.193
R.m.s.d., bond lengths (A˚) 0.021
R.m.s.d., bond angles () 1.95
Ramachandran plot statistics (%)
Favoured 98.0
Allowed 2.0
Outliers 0.0
positive selection of non-synonymous mutations that evade
the binding of neutralizing antibodies which create a steric
blockage to receptor binding. A more detailed analysis of the
surface residues of the LpfD adhesin domain reveals two
discrete zones with increased sequence conservation, pointing
to the putative receptor-binding site(s). A first high-similarity
region, ‘HSR1’, is located near the distal tip of the N-terminal
domain and is composed of the highly conserved surface-
localized residues Ala1, Asp2, Glu53, Pro55 and Pro57
(Fig. 6b; Supplementary Fig. S3). This region contains both
disulfide bridges of the adhesin domain: between Cys6 and
Cys52 and between Cys54 and Cys118. A second region,
‘HSR2’, coincides with a crevice in the molecular surface on
the side of the N-terminal domain and is delineated by resi-
dues Tyr67, Ala97, Gln113, Glu117, Trp125 and Thr126
(Fig. 6c). Other than these two regions, conserved surface-
localized residues map to the interdomain contact region, as
discussed above.
To further evaluate the role of HSR1 or HSR2 as candidate
receptor-binding sites, we compared their location and struc-
tural topology with those of confirmed ligand-binding sites in
fimbrial adhesins of known structure. A structural homology
search using the DALI server and the LpfD adhesin domain
(residues 1–183) found the Klebsiella pneumoniae adhesin
MrkD, the E. coli adhesin F17-G (GafD) and E. coli FimH as
the best-scoring homologues (Z-scores of 11.1, 10.8 and 6.8,
respectively). Strikingly, despite their low sequence similarity
(31 and 33%, respectively), MrkD and F17-G (GafD) show a
high structural homology to the LpfD adhesin. Super-
imposition of the MrkD (PDB entry 3u4k), F17f-G (GafD;
PDB entry 1zk5) and FimH (in
both low-affinity and high-affinity
conformations; PDB entries 3jwn
and 2vco, respectively) lectin
domains with LpfD1–183 corrobo-
rates the overall match of LpfD
with MrkD, F17f-G and FimH
(Supplementary Fig. S2). The
FimH adhesin binds terminal
mannose residues in epithelial
high-mannose glycoproteins.
Mannose binding is determined
by a defined receptor-binding
pocket located at the distal tip of
the lectin domain formed by the
N-terminus and loops consisting
of residues 45–54 and 135–142
(Fig. 6b; Supplementary Fig. S3).
This region coincides with HSR1
in the LpfD adhesin (Fig. 6b).
However, the local conformation
in this region is markedly
different in both adhesins
(Supplementary Fig. S3). The
equivalent secondary-structure
elements in LpfD (L1, L2, L3 and
the N-terminal -strand) are
disulfide-bonded and close off the
binding pocket, as seen in FimH.
Instead, they give rise to a
shallow molecular surface that
would be more compatible with
the formation of protein–protein
interactions or with the binding of
more extended oligosaccharides,
as is seen for the binding inter-
actions of PapG or FedF in their
globoside (GbO4) or type 1 blood
group A interactions, respectively
(Dodson et al., 2001; Moonens et
al., 2012). To evaluate the role of
HSR1 in LPF-mediated adhesion,
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Figure 6
Sequence conservation in LpfD and comparison with the fimbrial adhesins FimH, F17-G (GafD) and
MrkD. (a) Surface representation of full-length LpfDENte. The boxed regions are enlarged in (b) and (c).
(b) Detailed view of HSR1 in the adhesin domain of LpfD and the corresponding binding pocket of FimH
with oligomannose-3 (PDB entry 2vco). (c) Detailed view of HSR2 in the adhesin domain of LpfD and the
corresponding binding pockets of F17-G (GafD) with GlcNAc (PDB entry 1zk5) and of MrkD (PDB entry
3u4k). All models are shown in an equivalent orientation after structural alignment. LpfDENte is coloured
blue/white/yellow according to residue conservation, with blue and yellow the highest and the lowest level
of conservation, respectively. The LpfE N-terminal extension is coloured green.
we followed the binding of two LpfD mutants, E53A and
E53K (Glu53 was chosen for its central location in the HSR1
region and associated surface pocket), to mouse ileal tissue
sections (Supplementary Fig. S4). However, neither mutant
was found to alter LpfD binding in our experimental setup.
In addition to HSR1, we evaluated the possible role of
HSR2 in LPF adhesion. Remarkably, the overall structural
homology between LpfD and the MrkD and GafD adhesin
domains extends to the topology of the solvent-accessible
surface of the molecules near HSR2. In particular, F17-G
(GafD) and MrkD contain a glycan-binding pocket along the
side of the lectin domain (Buts et al., 2005; Reˆgo et al., 2012)
that is in an equivalent position to the pocket delimited by
Tyr67, Ala97, Gln113, Glu117, Trp125 and Thr126 revealed in
the LpfDENte structure. In F17-G (GafD) a co-crystal structure
showed this pocket to bind a GlcNAc residue (Buts et al., 2003,
2005) and in MrkD mutational disruption showed the pocket
to be involved in type V collagen binding by the adhesin, in
conjunction with a second collagen-binding region on the
surface of the adhesin (Sebghati et al., 1998; Reˆgo et al., 2012).
However, a mutant LpfDENte in which Gln113 was substituted
by Ala failed to show a significant reduction in a fluorescence-
based binding assay using mouse ileal tissue sections
(Supplementary Fig. S4). Our observations of native-like ileal
binding of the tested HSR1-localized (Glu53) and HSR2-
localized (Gln113) mutants may argue against a critical role of
either region in LPF-mediated adherence, although it cannot
be excluded that mutational disruption of a single residue in
the putative LpfD binding site is insufficient to give a
phenotype in the immunofluorescence microscopy assay,
where receptor-binding sites are present in high concentra-
tion. Of note, at least for MrkD, receptor binding was also
found to be localized in two binding zones.
Given the striking structural similarity of LpfD to MrkD
from K. pneumoniae, we sought to evaluate the possibility that
LPF could bind intestinal collagen. Therefore, slides of mouse
small intestine sections were pre-incubated with collagenase
prior to the addition of DyLight 650-labelled LpfDENte and
fluorescence microscopy analysis. This pre-treatment with
collagenase obliterated binding of LpfDENte to the ileal tissue
sections (Fig. 7a). Of note, collagen types I, III and V have
previously been shown to be implicated in the symptomatic
presentation of CD (Alexakis et al., 2004). To determine which
extracellular matrix (ECM) protein or proteins represent the
LPF receptor in the ileal epithelium, in vitro binding of
LpfDENte to isolated human collagen types I, III, IV and V
(type II collagen is restricted to cartilage), laminin and
fibronectin was assessed by ELISA. LpfD strongly adhered to
fibronectin, and showed weaker levels of binding to collagen V
and laminin (Fig. 7b). No binding above the background was
observed for collagens I, III or IV (Fig. 7b).
4. Conclusion
Despite the high level of interest in the study of CD patho-
genesis, little is known about the molecular interplay with the
bacteria implicated in CD onset and/or sustenance. AIEC
have been identified as a commonly enriched E. coli strain in
lesions. Long polar fimbriae in the model AIEC LF82 were
found to play an important role in its attachment and invasion
at the PP sites. Therefore, we sought a molecular and struc-
tural understanding of LPF-mediated adherence. We recom-
binantly produced the putative LPF adhesin LpfD as a soluble,
self-complemented construct by C-terminal fusion with the
N-terminal extension peptide of the LpfE pilus subunit. Using
fluorescence microscopy, we show that LpfD is responsible for
LPF binding to mouse intestinal tissue. No LpfD binding was
observed in mouse bladder sections, arguing for an LPF-
mediated tropism to the intestinal mucosa. Ileal LpfD binding
was found to be sensitive to mouse anti-LpfD serum, but
proved resistant to pre-treatment of the tissue sections with
O- or N-glycosidases. In addition, interrogation of the CFG
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Figure 7
Assessment of the putative collagen-binding properties of LpfDENte. (a)
Fluorescence microscopy of a murine small intestine section following
collagenase pre-treatment prior to incubation with DyLight 650-labelled
LpfDENte (an untreated control is shown in Fig. 2b). (b) Binding of
LpfDENte to collagen types I, III, IV and V, laminin and fibronectin. The
negative control was a microtitre plate well coated with PBS and blocked
with BSA and the positive control was a microtitre plate well coated with
LpfDENte. The columns and error bars represent the mean and the
standard error of the mean, respectively, from three separate experiments
(each performed in triplicate).
glycan array version 5.1 with LpfDENte did not reveal the
presence of a glycan receptor in the array. Whereas LPF-
mediated binding of AIEC LF82 to intact mouse or human
ileal resections was previously found to show tropism to PP-
localized M cells (Chassaing et al., 2011), our binding studies
with the purified LPF adhesin LpfD reveal a broader binding
profile that includes the epithelial and subepithelial tissue
throughout the ileum. Co-staining with anti-Muc2 antibodies
showed that this LpfD binding is excluded from the mucus
layer. In the healthy gut, a thick mucus layer forms a shielding
barrier that prevents direct contact between the intestinal
epithelium and the gut microbiota. At the PP, the mucus
barrier is reduced and specialized epithelial cells, called M
cells, now come into direct contact with the luminal micro-
biota.
Based on our data, we propose that the LpfD receptor is
present throughout the ileal mucosa and that the apparent
M-cell tropism for LPF-mediated bacterial adherence is a
result of the reduced mucus shielding at the PP. Therefore, a
compromised mucus layer could result in the exposure of the
LPF receptor and lead to AIEC binding at sites of mucosal
injury or depletion of goblet cell secretory function owing to
inflammation or transformation (McCormick et al., 1990; Kim
& Ho, 2010). Recent studies showed that a compromised
mucin layer in Muc2 mucin-deficient mice led to increased
bacterial adherence and the spontaneous development of
colitis (Van der Sluis et al., 2006; Johansson et al., 2008). LPF
could thus play a major role in the increased AIEC adherence
during inflammatory bowel disease. Our in vitro binding
studies and LpfD staining patterns of mouse intestinal histo
tissue sections suggest that one or more ECM proteins might
be receptors for LPF-mediated bacterial adherence. The
ELISA assays performed in this work using several major
ECM proteins present in the intestinal epithelium showed a
strong and direct in vitro binding of LpfD to fibronectin, as
well as weaker binding to laminin and collagen type V. These
proteins, as well as other ECM proteins, are generally loca-
lized in the epithelial basement membrane, where they are not
available for interaction with luminal bacteria. However,
during infection ECM components can be found partially
degraded and exposed to the intestinal lumen, now becoming
targets for the adherence of pathogenic bacteria (Vanlaere &
Libert, 2009). Also, an apical secretion of fibronectin has been
observed in human polarized intestinal epithelial cells exposed
to physiological concentrations of adenosine, a ubiquitous
pro-inflammatory signalling molecule. Under these conditions,
fibronectin was accessible from the intestinal lumen and
mediated the adherence and invasion of epithelial cells by
S. enterica serovar Typhimurium and enteroaggregative E. coli
(Walia et al., 2004; Farfan et al., 2008).
An earlier study by Fitzherny and coworkers found that
LPF in EHEC O157:H7 (i.e. Lpf1–3) targeted the bacteria to
the PP in human in vitro gut tissue cultures, but noted that
deletion of either or both of the lpfA genes maintained PP
binding and additionally expanded the tropism of the bacteria
to include the small intestine (Fitzhenry et al., 2006). The
potential ability of lpf expression to upregulate or down-
regulate the expression of other fimbrial operons is suggested
as a possible explanation of this feature. Here, using purified
LpfD adhesin (LpfDENte) from AIEC strain LF82, we were
able to take a first step in the identification of a receptor for
AIEC LPF (i.e. Lpf1–2). We found that collagenase pre-
treatment of ileal tissue sections resulted in a complete loss of
LpfDENte binding. Direct binding assays showed that LpfD
binds to fibronectin and to a lesser extent to laminin and
collagen type V. Strikingly, the LpfD crystal structure reveals
a close structural homology to the K. pneumoniae adhesin
MrkD, which is known to bind type V collagen (Tarkkanen et
al., 1990). The structural homology between MrkD and LpfD
includes the presence of a pocket on the side of the adhesin
domain. In MrkD, collagen binding was found to depend on
the combined presence of the conserved binding pocket and a
second region on the side of the adhesin domain (Reˆgo et al.,
2012). The results presented here suggest further investiga-
tions into the identity of the LpfD receptor should include the
direction of the ECM proteins, especially since collagen
accumulation has been observed in the intestine during the
course of CD (Alexakis et al., 2004).
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